ABBV vs MRVL: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Marvell Technology, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Marvell Technology, Inc. · Technology
$258.95
-11.4% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
ABBV has more upside to fair value
(-1.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
MRVL |
| Current Price |
$261.70 |
$258.95 |
| Fair Value Estimate |
$259.04 |
$229.46 |
| Upside to Fair Value |
-1.0%
|
-11.4%
|
| Market Cap |
$462.4B |
$226.8B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
48.0x
|
| Price / Sales |
7.2x
|
24.0x
|
| Price / FCF |
23.6x
|
134.3x
|
| Revenue Growth YoY |
+10.2%
|
+36.5%
|
| Gross Margin |
71.5%
|
51.4%
|
| Operating Margin |
29.3%
|
16.7%
|
| Return on Equity |
-136.5%
|
16.2%
|
| Dividend Yield |
2.61% |
0.09% |
| FCF Yield |
4.25%
|
0.74%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Marvell Technology is a data infrastructure semiconductor specialist that designs custom AI accelerators, electro-optics DSPs, ethernet switching, storage controllers and interconnect silicon for hyperscale data centers, communications and carrier markets, employing roughly 7,480 people under CEO Matthew J. Murphy. Business quality is genuinely high on the demand side: revenue grew 36.5% year ove…
Accumulation Zones
| Metric |
ABBV |
MRVL |
| Zone Low |
$194.28 |
$172.09 |
| Zone High |
$220.18 |
$195.04 |
| In Buy Zone? |
No
|
No
|